Preventing your blindness through innovation

Innovative Eye Care Solutions

Recornea technologies prevent blindness through proprietary technology that creates innovative minimally-invasive products for ophthalmic applications. The technology couples minimally invasive surgery with biocompatible and bio-enhanced devices to treat diseases of the eye.

Our technology:

• Nitinol A super elastic, shape-memory alloy.
• Biocompatible devices designed for natural integration/engineered for safety.
• Minimally invasive procedures Faster healing, less pain.

Pioneering the Future of Ophthalmology

RECORNEA pioneers advanced medical solutions for diseases of the eye. Our flagship GROSSO® Reshaper is the world's first-ever nitinol intracorneal implant designed to treat keratoconus, a condition that causes progressive thinning and bulging of the cornea resulting in poor quality of vision. By leveraging the unique properties of shape-memory and super-elastic materials, we are developing a pipeline of innovative minimally-invasive devices to address a wide range of ocular conditions, including glaucoma and keratoconus.

Supported by Fundings & Patents

Recornea raised around €4.4 M in non-dilutive and €1.4 M in dilutive funding for the core platform proprietary technology. Recornea will spin out multiple innovative products such as for glaucoma related ailments and others in the coming years.